[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO333165B1 - Forbindelse og sammensetning, og anvendelse av samme - Google Patents

Forbindelse og sammensetning, og anvendelse av samme Download PDF

Info

Publication number
NO333165B1
NO333165B1 NO20052529A NO20052529A NO333165B1 NO 333165 B1 NO333165 B1 NO 333165B1 NO 20052529 A NO20052529 A NO 20052529A NO 20052529 A NO20052529 A NO 20052529A NO 333165 B1 NO333165 B1 NO 333165B1
Authority
NO
Norway
Prior art keywords
compound
dimethyl
group
alkyl
pyridyl
Prior art date
Application number
NO20052529A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052529L (no
Inventor
Norimasa Kanamitsu
Masakazu Yoshimura
Haruo Kuriyama
Takashi Tamura
Kouhei Toyooka
Original Assignee
Maruishi Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32375878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO333165(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Maruishi Pharma filed Critical Maruishi Pharma
Publication of NO20052529L publication Critical patent/NO20052529L/no
Publication of NO333165B1 publication Critical patent/NO333165B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/62—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles
    • C07D209/64—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
NO20052529A 2002-11-26 2005-05-26 Forbindelse og sammensetning, og anvendelse av samme NO333165B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002342399 2002-11-26
PCT/JP2003/014986 WO2004048332A1 (ja) 2002-11-26 2003-11-25 イソインドリン誘導体

Publications (2)

Publication Number Publication Date
NO20052529L NO20052529L (no) 2005-06-23
NO333165B1 true NO333165B1 (no) 2013-03-25

Family

ID=32375878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052529A NO333165B1 (no) 2002-11-26 2005-05-26 Forbindelse og sammensetning, og anvendelse av samme

Country Status (23)

Country Link
US (2) US7521451B2 (pt)
EP (1) EP1566378B1 (pt)
KR (1) KR101149978B1 (pt)
CN (1) CN100548980C (pt)
AR (1) AR042139A1 (pt)
AU (1) AU2003284669B2 (pt)
BR (1) BR0316645A (pt)
CA (1) CA2505029C (pt)
DK (1) DK1566378T3 (pt)
EC (1) ECSP055886A (pt)
ES (1) ES2393645T3 (pt)
IL (1) IL168477A (pt)
MX (1) MXPA05005580A (pt)
NO (1) NO333165B1 (pt)
NZ (1) NZ539834A (pt)
PE (1) PE20040698A1 (pt)
PL (1) PL376890A1 (pt)
PT (1) PT1566378E (pt)
RU (1) RU2343145C2 (pt)
TW (1) TWI320408B (pt)
UY (1) UY28094A1 (pt)
WO (1) WO2004048332A1 (pt)
ZA (1) ZA200503697B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200602318A (en) * 2004-05-24 2006-01-16 Maruishi Pharma Neuropathic pain control composition
US8796313B2 (en) * 2005-11-01 2014-08-05 Janssen Pharmaceutica N.V. Substituted dihydroisoindolones as allosteric modulators of glucokinase
US8110681B2 (en) 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
US20090291983A1 (en) * 2006-07-12 2009-11-26 Astrazeneca Ab 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents
TWI417100B (zh) * 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
EP2573080A1 (en) * 2007-09-27 2013-03-27 The United States of America, as Represented by the Secretary, Department of Health and Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
GB0811643D0 (en) 2008-06-25 2008-07-30 Cancer Rec Tech Ltd New therapeutic agents
JP6409004B2 (ja) * 2013-01-28 2018-10-17 ハー・ルンドベック・アクチエゼルスカベット ソルチリン阻害剤としてのｎ置換された５置換フタルアミド酸
CN105254554B (zh) * 2014-07-14 2018-01-30 南开大学 一种制备异吲哚啉酮类化合物的方法
CN104803905B (zh) * 2015-04-17 2017-10-10 复旦大学 一种合成异吲哚啉‑1‑酮衍生物的方法
ITRM20150196A1 (it) * 2015-05-05 2016-11-05 Univ Degli Studi Di Salerno Isoindolinoni, procedimenti per la produzione di loro derivati chirali e impiego di questi ultimi
GB201517216D0 (en) 2015-09-29 2015-11-11 Cancer Res Technology Ltd And Astex Therapeutics Ltd Pharmaceutical compounds
GB201517217D0 (en) 2015-09-29 2015-11-11 Astex Therapeutics Ltd And Cancer Res Technology Ltd Pharmaceutical compounds
GB201704965D0 (en) 2017-03-28 2017-05-10 Astex Therapeutics Ltd Pharmaceutical compounds
GB201704966D0 (en) 2017-03-28 2017-05-10 Astex Therapeutics Ltd Pharmaceutical compounds
CN110698445B (zh) * 2018-07-09 2023-05-12 四川大学 一类3-胺烷基苯酞类化合物、其制备方法和用途
US20220388978A1 (en) * 2019-08-27 2022-12-08 Regents Of The University Of Michigan Cereblon e3 ligase inhibitors
CN110498759A (zh) * 2019-09-12 2019-11-26 天津瑞岭化工有限公司 异吲哚啉酮类化合物的合成方法
TW202140448A (zh) * 2020-01-16 2021-11-01 大陸商江蘇恆瑞醫藥股份有限公司 並環醯亞胺類衍生物、其製備方法及其在醫藥上的應用
WO2021143816A1 (zh) * 2020-01-16 2021-07-22 江苏恒瑞医药股份有限公司 稠合酰亚胺类衍生物、其制备方法及其在医药上的应用
CN114539124B (zh) * 2022-02-28 2023-07-21 大连大学 一种对映选择性合成n,3-二取代-1-异吲哚啉酮化合物的方法
CN114394926B (zh) * 2022-02-28 2023-06-27 大连大学 N,3-二取代-1-异吲哚啉酮类化合物的高产率合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2101081B1 (pt) 1970-08-19 1974-01-11 Rhone Poulenc Sa
US3679686A (en) * 1970-09-09 1972-07-25 Janssen Pharmaceutica Nv N-(bicycloamino-alkanoyl)-anilines
FR2117740B1 (pt) 1970-12-14 1974-04-12 Rhone Poulenc Sa
JPS4712322U (pt) 1971-03-09 1972-10-13
GB1472793A (en) 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
OA05287A (fr) 1975-04-07 1981-02-28 Rhone Poulenc Ind Nouveaux composés hétérocycliques et leur préparation.
JPS58189163A (ja) 1982-04-02 1983-11-04 Takeda Chem Ind Ltd 縮合ピロリノン誘導体
WO1983003410A1 (en) * 1982-04-02 1983-10-13 Takeda Chemical Industries Ltd Isoindolin derivatives
DE3378763D1 (en) 1982-04-02 1989-02-02 Takeda Chemical Industries Ltd Condensed pyrrolinone derivatives, and their production
US5932613A (en) 1996-07-03 1999-08-03 Millennium Pharmaceuticals, Inc. Anticancer agents
KR19980074060A (ko) * 1997-03-21 1998-11-05 김윤배 신규한 치환된 3,4-디알콕시페닐 유도체
EP1014962A4 (en) * 1997-06-26 2007-06-27 Lilly Co Eli ANTITHROMBOTIC AGENTS
AU777517B2 (en) * 1999-06-10 2004-10-21 Bridge Pharma, Inc. Dermal anesthetic agents
TW200602318A (en) * 2004-05-24 2006-01-16 Maruishi Pharma Neuropathic pain control composition

Also Published As

Publication number Publication date
AU2003284669B2 (en) 2009-11-12
ZA200503697B (en) 2006-10-25
UY28094A1 (es) 2004-06-30
HK1079201A1 (en) 2006-03-31
US20090170835A1 (en) 2009-07-02
CN1741995A (zh) 2006-03-01
KR20050070140A (ko) 2005-07-05
TW200416218A (en) 2004-09-01
CN100548980C (zh) 2009-10-14
PE20040698A1 (es) 2004-10-30
BR0316645A (pt) 2005-10-11
WO2004048332A1 (ja) 2004-06-10
NZ539834A (en) 2007-08-31
CA2505029A1 (en) 2004-06-10
EP1566378B1 (en) 2012-08-15
ECSP055886A (es) 2005-09-20
RU2343145C2 (ru) 2009-01-10
US7521451B2 (en) 2009-04-21
EP1566378A1 (en) 2005-08-24
DK1566378T3 (da) 2012-11-12
ES2393645T3 (es) 2012-12-26
AU2003284669A1 (en) 2004-06-18
AR042139A1 (es) 2005-06-08
RU2005120003A (ru) 2006-01-20
US20060052392A1 (en) 2006-03-09
IL168477A (en) 2010-11-30
EP1566378A4 (en) 2011-03-23
PL376890A1 (pl) 2006-01-09
CA2505029C (en) 2012-03-20
PT1566378E (pt) 2012-11-29
TWI320408B (en) 2010-02-11
KR101149978B1 (ko) 2012-06-01
NO20052529L (no) 2005-06-23
MXPA05005580A (es) 2005-11-23

Similar Documents

Publication Publication Date Title
NO333165B1 (no) Forbindelse og sammensetning, og anvendelse av samme
EP0586490B1 (fr) Derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent
KR101216296B1 (ko) 티에노피리디논 화합물 및 치료 방법
US20040242589A1 (en) 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
US20070004791A1 (en) 3,6-disubstituted azabicyclo {3.1.0} hexane derivatives useful as muscarnic receptor antagonists
JPH01316363A (ja) ピペラジン誘導体およびその塩
WO2004091605A1 (ja) アルキルエーテル誘導体またはその塩を含有する網膜神経疾患の予防・治療剤
RU2709810C2 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[3,4-с]ПИРИДИНА
KR100331407B1 (ko) 신경이완제등으로이용되는n-치환아자비시클로헵탄유도체
JP6231621B2 (ja) 新規ベンゾアゼピン誘導体及びその医薬用途
US6391896B1 (en) 3-Tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
JP4205559B2 (ja) イソインドリン誘導体
CA2565061A1 (en) Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents
JP2011006366A (ja) 新規チオフェンカルボキサミド誘導体及びその医薬用途
RU2803243C2 (ru) Антагонист dp
TWI681960B (zh) 苯并咪唑類衍生物及其製備方法及其在醫藥上的用途
BG109768A (bg) Пиперазинови производни на алкилови оксиндоли
HK1079201B (en) Isoindoline derivative
KR20050023401A (ko) 무스카린 수용체 길항제로서 사용가능한 3,6-이치환된아자비시클로 [3.1.0]헥산 유도체
KR20050023400A (ko) 무스카린 수용체 길항제로서의 아자비시클로 유도체

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MARUISHI PHARMACEUTICAL CO LTD, JP

MM1K Lapsed by not paying the annual fees